Company Overview and News

0
Rogers takes Winnipeg radio host off the air, apologizes for his 'hurtful' comments about transgender people

4h cbc.ca
A Winnipeg radio personality will be off the air Tuesday morning, a day after making comments about transgender people that Rogers Media said were contrary to its "standards and core values."
RCIAF RCI

2
Veeva Systems' Development Cloud Platform Picked by Idorsia

5h zacks
Shares of Veeva Systems (VEEV - Free Report) climbed 3.5% to $82.23 following the company’s recent collaboration with Idorsia Pharmaceuticals Ltd.
RCIAF NOBGF RCI N21 SYK VEEV NOBGY GHDX SGH

10
Americans on a Spring Spending Spree: Top 5 Gainers

6h zacks
Headline retail sales rose for the fifth successive month in June, with health & personal care stores, building materials and even online shopping seeing an uptick in sales. Sales at bars and restaurants surged during late spring to the highest level in about three years.
GRPN RCIAF NOBGF RCI N21 NOBGY DRI CVS SGH TAST

7
Rogers Communications (RCI) Q2 Earnings: What's in the Cards?

18h zacks
Rogers Communications Inc. (RCI - Free Report) is set to release second-quarter 2018 results on Jul 19. The company beat the Zacks Consensus Estimate in the trailing four quarters, with an average positive surprise of 6.64%. In first-quarter 2018, earnings of 71 cents per share outpaced the Zacks Consensus Estimate of 60 cents. Total revenues of $2.88 billion also surpassed the Zacks Consensus Estimate of $2.
BCE NOC RCIAF RCI SJR.B TWTR SJR NFLX SJRWF SJR.PR.A SJR.A

100
Big money tests marijuana waters, with hedge funds leading charge

2018-07-12 thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com
STZ.B KHRNF RCI ACBFF DTK TXCX STZ CGC RCIAF TWMJF ACB BLK APH WEED APHQF OGRMF GWP OGI

93
CANADA STOCKS-TSX rises as financials gain from strong jobs data

2018-07-06 reuters
(Reuters) - Canada’s main stock index edged higher on Friday as financial stocks gained after a strong domestic jobs data cemented expectations of fourth interest rate hike of the year next week.
BAMGF RCI ACBFF TCLAF CG CGEAF TCLCF CGC BCE CAGDF RCIAF TWMJF ACB WEED BAMKF BAM

25
34 Of 72 Communication Services High Yield Stocks Claim 'Safer' Dividends For June

2018-07-01 seekingalpha
Ten 'safer' dividend Communication Services equities averaged 39.8% gains. Top gainer Telecom Argentina produced a 75.85% net per broker targets 6/27/18.
PCCWY ORAN VODAF RCI CHLKF VOD VOD CHJHF CHA VZA 0941 RCIAF CHL VDMCY PCWLF VODPF VZ 0728 MGYTF

0
Calgary senior waited months for Fido to refund thousands after accidental bill overpayment

2018-06-25 cbc.ca
After accidentally overpaying her cellphone bill by thousands, a Calgary senior who is battling Stage 4 cancer and living on a pension says she waited months for Fido reimburse her money.
RCIAF RCI

14
Micro Caps: It's All About Where You Look

2018-06-16 seekingalpha
There are always bargains in micro caps, but it takes looking to find them and avoid pitfalls.
PHNHF ATUSF RCIAF WHR RCI TWX NYRT TWC AVDWF ROST

0
Ottawa orders probe of high-pressure telecom sales tactics

2018-06-14 thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com
RCIAF RCI BCEXF

0
Rogers Media cuts 75 jobs in digital content and publishing

2018-06-14 thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com
RCIAF RCI

0
Rogers cuts 75 jobs from digital content and publishing team

2018-06-14 cbc.ca
Rogers Communications is cutting the size of its digital content and publishing team by about one-third.
RCIAF RCI

28
Is Rogers Communications a Great Stock for Value Investors?

2018-06-11 zacks
Value investing is easily one of the most popular ways to find great stocks in any market environment. After all, who wouldn’t want to find stocks that are either flying under the radar and are compelling buys, or offer up tantalizing discounts when compared to fair value?
WFC WFCNP WFC.WS RCI WFC.PRL WFC.PRJ WFC.PRT RCIAF WFC.PRR WFC.PRQ WFC.PRP WFC.PRO WFC.PRN WFC.PRY WFC.PRX WFC.PRW WFC.PRV

15
Vice Media Was Built on a Bluff

2018-06-11 nymag
It was sunny in Williamsburg on the last Wednesday in May, which also happened to be the second day of a new era at Vice Media. Visitors were still required to sign in on a tablet that featured an image of a woman’s red lips opened wide to reveal a tab of acid, but the TV screens in the lobby promoted a forthcoming seminar on “How to Be an Ally.” On the company’s sprawling roof-deck overlooking the East River, Nancy Dubuc, the former head of A&E who had started as Vice’s CEO the day before, sat in a lounge chair with Dominique Delport, a French advertising executive recently hired as the company’s chief revenue officer.
RCIAF GEC GE RCI GNE NYTAB

4
PRESS DIGEST-Canada - June 6

2018-06-06 reuters
June 6 (Reuters) - The following are the top stories from selected Canadian newspapers. Reuters has not verified these stories and does not vouch for their accuracy.
ENBBF ENB RCIAF RCI EBBNF ENB

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

12h - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

13h - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...